{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:43:05Z","timestamp":1792604585684,"version":"4.5.0"},"reference-count":321,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.bioorg.2019.103299","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T01:47:23Z","timestamp":1568857643000},"page":"103299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Critical evaluation of current Alzheimer\u2019s drug discovery (2018\u201319) &amp; futuristic Alzheimer drug model approach"],"prefix":"10.1016","volume":"93","author":[{"given":"Atukuri","family":"Dorababu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103299_b0005","doi-asserted-by":"crossref","first-page":"b158","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer\u2019s disease","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"issue":"9770","key":"10.1016\/j.bioorg.2019.103299_b0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2019.103299_b0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2019.103299_b0020","first-page":"1545","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study","volume":"388","author":"GBD 2015 Disease Injury Incidence Prevalence Collaborators (October 2016)","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2019.103299_b0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archneur.65.3.329","article-title":"Genome-wide association studies in Alzheimer disease","volume":"65","author":"Waring","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bioorg.2019.103299_b0030","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.1038\/399a023","article-title":"Translating cell biology into therapeutic advances in Alzheimer's disease","volume":"399","author":"Selkoe","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2019.103299_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.12779\/dnd.2018.17.4.131","article-title":"Genetics of Alzheimer's disease","volume":"17","author":"Kim","year":"2018","journal-title":"Dement. Neurocogn. Disord."},{"key":"10.1016\/j.bioorg.2019.103299_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J. Neurol. Neurosurg. Psych."},{"key":"10.1016\/j.bioorg.2019.103299_b0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1755-5949.2010.00175.x","article-title":"Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?","volume":"16","author":"Martorana","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bioorg.2019.103299_b0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2019.103299_b0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","article-title":"Alzheimer's disease-do tauists and baptists finally shake hands?\u201c","volume":"25","author":"Mudher","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0065","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2174\/15680266113139990139","article-title":"Dual inhibitors of \u03b2-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates","volume":"13","author":"Viayna","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0070","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acschemneuro.7b00461","article-title":"Design, synthesis, and biological evaluation of 1-benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer\u2019s agents","volume":"9","author":"Panek","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b0075","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer\u2019s disease","volume":"20","author":"Lim","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-2004-6409","article-title":"Estrogen increasesbrain expression of the mRNA encoding transthyretin, an amyloid beta scavenger protein","volume":"6","author":"Tang","year":"2004","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bioorg.2019.103299_b0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.lfs.2008.12.006","article-title":"Inactivation of cholinesterase induced by non-steroidal anti-inflammatory drugs with horseradish peroxidase: implication for Alzheimer's disease","volume":"84","author":"Muraoka","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2019.103299_b0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2014.02.045","article-title":"synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"76","author":"Qiang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0095","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/anie.200700256","article-title":"A small molecule targeting the multifactorial nature of Alzheimer's disease","volume":"46","author":"Cavalli","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2019.103299_b0100","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1016\/j.bmc.2018.11.015","article-title":"Discovery of novel 2,5-dihydroxyterephthalamide derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Song","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/jm049112h","article-title":"Rational approach to discover multipotent anti-Alzheimer drugs","volume":"48","author":"Rosini","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0110","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejmech.2013.03.051","article-title":"Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease","volume":"64","author":"Xie","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0115","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/cbdd.12588","article-title":"Synthesis and anticholinesterase activity of 4-hydroxycoumarin derivatives containing substituted benzyl-1,2,3-triazole moiety","volume":"86","author":"Bagheri","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2019.103299_b0120","doi-asserted-by":"crossref","first-page":"e00023","DOI":"10.1002\/prp2.23","article-title":"From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's disease","volume":"2","author":"Tarozzi","year":"2014","journal-title":"Pharma. Res. Per."},{"key":"10.1016\/j.bioorg.2019.103299_b0125","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/j.bmcl.2010.05.022","article-title":"A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity","volume":"20","author":"Roussaki","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bioorg.2018.04.030","article-title":"Novel 3-phenylcoumarin\u2013lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease","volume":"79","author":"Jalili-Baleh","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0135","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1039\/C6MD00228E","volume":"7","author":"Tavari","year":"2016","journal-title":"MedChemComm."},{"key":"10.1016\/j.bioorg.2019.103299_b0140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ardp.201500117","volume":"348","author":"Szalaj","year":"2015","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2019.103299_b0145","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.bmc.2018.02.037","article-title":"Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-Nalkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and b-amyloid aggregation inhibitory activities as potential agents against Alzheimer\u2019s disease","volume":"26","author":"Xu","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0150","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1368-5031.2005.00562.x","article-title":"Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years","volume":"59","author":"Bullock","year":"2005","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bioorg.2019.103299_b0155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejmech.2015.08.061","article-title":"Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors","volume":"103","author":"Mostofi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0165","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1016\/j.bmc.2012.08.052","article-title":"Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors","volume":"20","author":"Alipour","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.03.012","article-title":"New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer\u2019s disease: design, synthesis, biological evaluation, and docking study","author":"Molazadeh","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103299_b0175","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/jm981101z","article-title":"Aminopyridazines as acetylcholinesterase inhibitors","volume":"42","author":"Contreras","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0180","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00044-014-1205-8","article-title":"Synthesis of some 3(2H)-pyridazinone and 1(2H)-phthalazinone derivatives incorporating aminothiazole moiety and investigation of their antioxidant, acetylcholinesterase, and butyrylcholinesterase inhibitory activities","volume":"24","author":"Yamali","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0185","first-page":"159","article-title":"Synthesis of some new 1 (2H)-phthalazinone derivatives and evaluation of their acetylcholinesterase and butyrylcholinesterase inhibitory activities","volume":"14","author":"Kilic","year":"2017","journal-title":"Lett. Drug. Des. Discov."},{"key":"10.1016\/j.bioorg.2019.103299_b0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bioorg.2018.05.006","article-title":"Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase","volume":"79","author":"Kilic","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2967\/jnumed.115.162370","article-title":"PET imaging of copper trafficking in a mouse model of Alzheimer disease","volume":"57","author":"Torres","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bioorg.2019.103299_b0200","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11481-012-9416-6","article-title":"Nanoprobing of the effect of Cu2+ cations on misfolding, interaction and aggregation of amyloid \u03b2 peptide","volume":"8","author":"Lv","year":"2013","journal-title":"J. Neuroimm. Pharm."},{"key":"10.1016\/j.bioorg.2019.103299_b0205","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1074\/jbc.M113.511345","article-title":"Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid \u03b2-fibrils in a redox cycle","volume":"289","author":"Parthasarathy","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0210","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1021\/acschemneuro.7b00187","article-title":"Dihydropyrimidine-thiones and clioquinol synergize to target \u03b2-amyloid cellular pathologies through a metal-dependent mechanism","volume":"8","author":"Tardiff","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b0215","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jaad.2017.11.056","article-title":"Phosphodiesterase 4 inhibitors","volume":"78","author":"Zebda","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioorg.2019.103299_b0220","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2019.103299_b0225","article-title":"Synthesis and evaluation of clioquinol-rolipram\/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease","author":"Hu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0230","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.2174\/092986711803414395","volume":"18","author":"Kostova","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0235","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","article-title":"A review on coumarins as acetylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"20","author":"Anand","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2012.12.046","volume":"62","author":"Duan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0245","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2017.07.055","volume":"139","author":"Lan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejmech.2018.01.055","article-title":"Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"146","author":"Jiang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0255","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/j.bmc.2014.06.057","article-title":"Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Abeta aggregation, and beta-secretase","volume":"22","author":"Sun","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0260","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejmech.2014.10.029","article-title":"In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors","volume":"89","author":"Pisani","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0265","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2174\/1568026615666150427113103","article-title":"Coumarins: auspicious cholinesterase monoamine oxidase inhibitors","volume":"15","author":"Orhan","year":"2015","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2018.09.010","article-title":"Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer\u2032s Disease: design, synthesis and biological evaluation","author":"He","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0275","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bioorg.2019.103299_b0280","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.0602922103","article-title":"Butyrylcholinesterase attenuates amyloid fibril formation in vitro","volume":"103","author":"Diamant","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2019.103299_b0285","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbi.2016.03.002","article-title":"Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-beta1-42 peptide in mice","volume":"56","author":"Souza","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bioorg.2019.103299_b0290","doi-asserted-by":"crossref","first-page":"90288","DOI":"10.1039\/C5RA19551A","article-title":"Discovery of new scaffolds from approved drugs as acetylcholinesterase inhibitors","volume":"5","author":"Chen","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.103299_b0295","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2014.06.078","article-title":"Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors","volume":"84","author":"Rohrig","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0300","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.bmc.2018.02.014","article-title":"Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: the design, synthesis of miconazole analogues targeting Alzheimer\u2019s disease","volume":"26","author":"Lu","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0305","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2009.12.044","article-title":"The history of the cholinergic hypothesis","volume":"221","author":"Contestabile","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0310","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbr.2016.06.051","article-title":"Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases","volume":"312","author":"Sadek","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0315","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1080\/14756366.2017.1347163","article-title":"Discovery of novel isoflavone derivatives as AChE\/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling","volume":"32","author":"Feng","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0320","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/cbdd.12981","article-title":"Design, synthesis, biological evaluation, and molecular docking of novel flavones as H3R inhibitors","volume":"90","author":"Wen","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2019.103299_b0325","article-title":"Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JMN:24:1:001","article-title":"Drug discovery for Alzheimer's disease: the end of the beginning","volume":"24","author":"Refolo","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b0335","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1016\/j.bmc.2013.06.065","article-title":"Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors","volume":"21","author":"Alpan","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0340","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ardp.200300795","article-title":"Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type","volume":"336","author":"Kapkova","year":"2003","journal-title":"Arch. Pharm. Pharm. Med. Chem"},{"key":"10.1016\/j.bioorg.2019.103299_b0345","article-title":"Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones","author":"Parlar","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0350","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1021\/jf802279h","article-title":"Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging","volume":"56","author":"Joseph","year":"2008","journal-title":"J. Agr. Food Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0355","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.neurobiolaging.2011.08.015","article-title":"Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer\u2019s disease","volume":"33","author":"Chang","year":"2012","journal-title":"Neurobiol. Ag."},{"key":"10.1016\/j.bioorg.2019.103299_b0360","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1016\/j.ejmech.2011.08.002","article-title":"Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced b-amyloid aggregation inhibitors","volume":"46","author":"Tang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0365","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.bmcl.2016.02.079","article-title":"Pterostilbene-Oacetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-b-amyloid aggregation and antioxidant properties for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Li","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b0370","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bioorg.2018.03.016","article-title":"Design, synthesis and evaluation of pterostilbene \u03b2-amino alcohol derivatives as multifunctional agents for Alzheimer\u2019s disease treatment","volume":"78","author":"Zheng","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0375","doi-asserted-by":"crossref","first-page":"16507","DOI":"10.1523\/JNEUROSCI.3647-11.2011","article-title":"Robust central reduction of amyloid-\u03b2 in humans with an orally available, non-peptidic b-secretase inhibitor","volume":"31","author":"May","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b0380","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/157488911795933938","article-title":"BACE inhibitors as potential drugs for the treatment of Alzheimer\u2019s disease: focus on bioactivity","volume":"6","author":"Evin","year":"2011","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103299_b0385","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.23642","article-title":"5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease","volume":"72","author":"Chu","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bioorg.2019.103299_b0390","doi-asserted-by":"crossref","first-page":"e70991","DOI":"10.1371\/journal.pone.0070991","article-title":"Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer\u2019s disease with plaques and tangles","volume":"8","author":"Chu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2019.103299_b0395","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bbagen.2008.01.017","article-title":"Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cellfree, cell-based and in silico studies reveal novel pharmacophore features","volume":"1780","author":"Shimmyo","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2019.103299_b0400","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejmech.2013.11.030","article-title":"Inhibition of LOX by flavonoids: a structure-activity relationship study","volume":"72","author":"Ribeiro","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0405","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jafc.6b03529","article-title":"Inhibition of human monoamine oxidase: biological and molecular modeling studies on selected natural flavonoids","volume":"64","author":"Carradori","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0410","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bmc.2010.01.071","article-title":"Targeting Alzheimer\u2019s disease: novel indanone hybrids bearing a pharmacophoric fragment of AP2238","volume":"18","author":"Rizzo","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0415","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/14756366.2019.1581184","article-title":"New flavonoid \u2013 N,N-dibenzyl(Nmethyl) amine hybrids: multi-target-directed agents for Alzheime\u0155s disease endowed with neurogenic properties","volume":"34","author":"Estrada-Valencia","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0420","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bmc.2011.12.002","article-title":"Structure\u2013activity relationships for naturally occurring coumarins as \u03b2-secretase inhibitor","volume":"20","author":"Marumoto","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0425","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1039\/b901969n","article-title":"In situ click chemistry: probing the binding landscapes of biological molecules","volume":"39","author":"Mamidyala","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2019.103299_b0430","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejmech.2013.10.024","article-title":"Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors","volume":"70","author":"Asadipour","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0435","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4","article-title":"Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks","volume":"41","author":"Lewis","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2019.103299_b0440","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejmech.2017.09.057","article-title":"Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease","volume":"141","author":"Iraji","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0445","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bioorg.2018.10.065","article-title":"Design, synthesis and anti-Alzheimer\u2019s activity of novel 1,2,3-triazolechromenone carboxamide derivatives","volume":"83","author":"Rastegari","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0450","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2174\/1568026615666150427113103","article-title":"Coumarins: auspicious cholinesterase and monoamine oxidase inhibitors","volume":"15","author":"Orhan","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0455","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1016\/j.ejmech.2011.07.017","article-title":"Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives","volume":"46","author":"Secci","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0460","doi-asserted-by":"crossref","first-page":"104122","DOI":"10.1039\/C5RA22296F","article-title":"Synthesis and evaluation of 6-substituted 3-arylcoumarin derivatives as multifunctional acetylcholinesterase\/monoamine oxidase B dual inhibitors for the treatment of Alzheimer\u2019s disease","volume":"5","author":"Wang","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.103299_b0465","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/14756366.2019.1574297","article-title":"Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents","volume":"34","author":"Yang","year":"2019","journal-title":"J. Enzyme Inhib. Med.l Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0470","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1021\/jm301659n","article-title":"Structure-based design of beta-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease","volume":"56","author":"Yuan","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0475","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bioorg.2018.01.017","article-title":"Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease","volume":"77","author":"Iraji","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0480","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bioorg.2018.11.038","article-title":"Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1,2,4-triazine scaffold containing pendant phenoxy methyl-1,2,3-triazole: Design, synthesis and biological evaluation","volume":"84","author":"Yazdania","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0485","doi-asserted-by":"crossref","first-page":"10345","DOI":"10.1021\/acs.jmedchem.7b01922","article-title":"Why are the majority of active compounds in the CNS domain natural products? A critical analysis","volume":"61","author":"Bharate","year":"2018","journal-title":"J Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0490","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1039\/c2md20076g","article-title":"Total synthesis and anti-cholinesterase activity of marine-derived bisindole alkaloid fascaplysin","volume":"3","author":"Bharate","year":"2012","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2019.103299_b0495","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuint.2015.07.018","article-title":"Plant alkaloids as drug leads for Alzheimer's disease","volume":"89","author":"Ng","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioorg.2019.103299_b0500","series-title":"Natural Products Targeting Clinically Relevant Enzymes","first-page":"93","article-title":"\u03b2-Secretase (BACE1) inhibitors from natural products","author":"Fang","year":"2017"},{"key":"10.1016\/j.bioorg.2019.103299_b0505","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5604\/12321966.1185777","article-title":"Anticholinesterase activity of selected phenolic acids and flavonoids \u2013 interaction testing in model solutions","volume":"22","author":"Szwajgier","year":"2015","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.bioorg.2019.103299_b0510","first-page":"1","article-title":"Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent","author":"Nuthakki","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0515","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2013.10.025","article-title":"R-flurbiprofen improves tau, but not A\u03b2 pathology in a triple transgenic model of Alzheimer\u2019s disease","volume":"1541","author":"Carreras","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0520","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bmc.2018.01.030","article-title":"Design, synthesis and evaluation of 4\u2032-OH-flurbiprofenchalcone hybrids as potential multifunctional agents for Alzheimer\u2019s disease treatment","volume":"26","author":"Cao","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0525","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1016\/j.bmcl.2012.08.080","article-title":"Antioxidant properties of Mannich bases","volume":"22","author":"Park","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b0530","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejmech.2014.10.076","article-title":"Mannich bases in medicinal chemistry and drug design","volume":"89","author":"Roman","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0535","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bmc.2019.01.040","article-title":"Discovery of 4\u2032-OH-flurbiprofen Mannich base derivatives as potential Alzheimer\u2032s disease treatment with multiple inhibitory activities","volume":"27","author":"Liu","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0540","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/ph7020113","article-title":"From single target to multi-target\/network therapeutics in Alzheimer's therapy","volume":"7","author":"Zheng","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2019.103299_b0545","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1039\/C4MD00069B","article-title":"Two diseases, one approach: multi-target drug discovery in Alzheimer's and neglected tropical diseases","volume":"5","author":"Prati","year":"2014","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.bioorg.2019.103299_b0550","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2015.01.058","article-title":"Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties","volume":"93","author":"Xie","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0555","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1016\/j.bmc.2015.08.012","article-title":"Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors","volume":"23","author":"Choi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0560","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.bmc.2014.03.032","article-title":"Synthesis and evaluation of ethyleneoxylated and allyloxylated chalcone derivatives for imaging of amyloid \u03b2 plaques by SPECT","volume":"22","author":"Fuchigami","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0565","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bioorg.2019.03.043","article-title":"Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer\u2019s disease","volume":"87","author":"Zhang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0570","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0575","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejmech.2013.09.024","article-title":"Multifunctional tacrine\u2013flavonoid hybrids with cholinergic, \u03b2-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease","volume":"69","author":"Li","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0580","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ejmech.2016.06.025","article-title":"Novel series of tacrine-tianeptine hybrids: Synthesis, cholinesterase inhibitory activity, S100B secretion and a molecular modeling approach","volume":"121","author":"Ceschi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0585","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ejmech.2018.01.014","article-title":"Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment","volume":"145","author":"Czarnecka","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0590","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","article-title":"The neuropharmacological basis for the use of memantine in the treatment of Alzheimer\u2019s disease","volume":"9","author":"Rogawski","year":"2006","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/j.bioorg.2019.103299_b0595","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2017.01.003","article-title":"The pharmacology of tacrine at N-methyl-d-aspartate receptors","volume":"75","author":"Horak","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psych."},{"key":"10.1016\/j.bioorg.2019.103299_b0600","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijpharm.2014.10.058","article-title":"Synthesis, biological activity, and biopharmaceutical characterization of tacrine dimers as acetylcholinesterase inhibitors","volume":"477","author":"Qian","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2019.103299_b0605","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/14756366.2017.1406485","article-title":"New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer\u2019s disease","volume":"33","author":"Czarnecka","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0610","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jpi.12162","article-title":"Melatonin: a well-documented antioxidant with conditional pro-oxidant actions","volume":"57","author":"Zhang","year":"2014","journal-title":"J. Pineal. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0615","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jpi.12267","article-title":"Melatonin: an ancient molecule that makes oxygen metabolically tolerable","volume":"59","author":"Manchester","year":"2015","journal-title":"J. Pineal. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0620","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/10715760802277388","article-title":"The neuroprotective role of melatonin against amyloid b peptide injected mice","volume":"42","author":"Masilamoni","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0625","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1016\/j.bmcl.2012.07.025","article-title":"Selected chromone derivatives as inhibitors of monoamine oxidase","volume":"22","author":"Legoabe","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b0630","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14756366.2018.1545766","article-title":"Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer\u2019s disease therapy","volume":"34","author":"Pachon-Angona","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0635","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pneurobio.2015.12.003","article-title":"Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer\u2019s disease","volume":"151","author":"Ismaili","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bioorg.2019.103299_b0640","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer\u2019s disease","volume":"33","author":"Leon","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2019.103299_b0645","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bmcl.2006.09.097","article-title":"Kojic acid and its manganese and zinc complexes as potential radioprotective agents","volume":"17","author":"Emami","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b0650","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14756366.2018.1538136","article-title":"Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer\u2019s disease therapy","volume":"34","author":"Dgachi","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0655","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1021\/jm070467l","article-title":"Quick assembly of 1,4\u2013diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease","volume":"50","author":"Qu","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0660","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejmech.2017.02.057","article-title":"Identification of dibenzylimidazolidine and triazole acetamide derivatives through virtual screening targeting amyloid beta aggregation and neurotoxicity in PC12 cells","volume":"130","author":"Das","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0665","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1039\/C7SC01269A","article-title":"Multi\u2013target\u2013directed phenol\u2013triazole ligands as therapeutic agents for Alzheimer's disease","volume":"8","author":"Jones","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2019.103299_b0670","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.3390\/molecules17078312","article-title":"From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer's disease","volume":"17","author":"Jiaranaikulwanitch","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103299_b0675","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bioorg.2019.03.058","article-title":"Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer\u2019s disease","volume":"87","author":"Kaura","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0680","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/14756366.2018.1443326","article-title":"Profiling donepezil template into multipotent hybrids with antioxidant properties","volume":"33","author":"Mezeiova","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0685","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","article-title":"Structure of acetylcholinesterase complexed with E2020 (Aricept\u00ae): implications for the design of new anti-Alzheimer drugs","volume":"7","author":"Kryger","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2019.103299_b0690","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1021\/acsmedchemlett.5b00483","article-title":"Design, synthesis, and evaluation of donepezil-like compounds as AChE and BACE-1 inhibitors","volume":"7","author":"Costanzo","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b0695","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejmech.2019.02.030","article-title":"Design and development of multitargetdirected N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease","volume":"167","author":"Sharma","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0700","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejmech.2016.05.014","article-title":"Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety","volume":"121","author":"Ghanei-Nasab","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0705","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejmech.2015.02.009","article-title":"Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors","volume":"93","author":"Baharloo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0710","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejmech.2014.01.017","article-title":"Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling","volume":"84","author":"Akrami","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0715","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1021\/acs.bioconjchem.7b00500","article-title":"Generation of clickable Pittsburgh compound B for the detection and capture of \u03b2-amyloid in Alzheimer's disease brain","volume":"28","author":"Diner","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0720","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1016\/j.bmc.2012.02.059","article-title":"Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids","volume":"20","author":"Huang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0725","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bioorg.2018.11.010","article-title":"Synthesis and biological evaluation of new N-benzylpyridinium-based benzoheterocycles as potential anti-Alzheimer\u2019s agents","volume":"83","author":"Salehi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0730","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ejmech.2018.05.004","article-title":"A review on flavonoidbased scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease","volume":"152","author":"Jalili-Baleh","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0735","first-page":"11","article-title":"Synthesis and evaluation of substituted 4,4a-dihydro-3H,10H-pyrano[4,3-b][1]benopyran-10-one as antimicrobial agent","author":"Kaur","year":"2013","journal-title":"ISRN Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0740","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.21873\/anticanres.12747","article-title":"Quantitative structure \u2013 cytotoxicity relationship of pyrano[4,3-b]chromones","volume":"38","author":"Nagai","year":"2018","journal-title":"Anticanc. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0745","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bioorg.2018.11.004","article-title":"Synthesis and biological evaluation of pyrano[4,3-b][1]benzopyranone derivatives as monoamine oxidase and cholinesterase inhibitors","volume":"83","author":"Takao","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0750","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bioorg.2017.11.012","volume":"76","author":"Kaya-Cavusoglu","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0755","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/molecules23010134","volume":"23","author":"Karrouchi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103299_b0760","series-title":"Multifunctional Enzyme Inhibition for Neuroprotection-A Focus on MAO, NOS and AChE Inhibitors, Drug Design and Discovery in Alzheimer\u2019s Disease","first-page":"291","author":"Rahman","year":"2015"},{"key":"10.1016\/j.bioorg.2019.103299_b0765","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bioorg.2018.11.016","article-title":"Synthesis and biological evaluation of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase inhibitors","volume":"84","author":"Tok","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0770","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4155\/fmc-2017-0031","article-title":"Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment","volume":"9","author":"Lalut","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0775","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/cn300095t","article-title":"5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10","volume":"4","author":"Cochet","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b0780","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fnagi.2013.00096","article-title":"Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease","volume":"5","author":"Giannoni","year":"2013","journal-title":"Front. Ag. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b0785","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-319-50174-1_15","article-title":"Role of s1 receptors in learning and memory and Alzheimer's disease-type dementia","volume":"964","author":"Maurice","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bioorg.2019.103299_b0790","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2011.12.047","article-title":"Neuroprotective effects of high affinity sigma 1 receptor selective compounds","volume":"1441","author":"Luedtke","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0795","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejmech.2018.10.064","article-title":"Novel multitarget-directed ligands targeting acetylcholinesterase and s1 receptors as lead compounds for treatment of Alzheimer's disease: synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase","volume":"162","author":"Lalut","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0800","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bioorg.2018.11.022","article-title":"Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: design, synthesis and biological evaluation","volume":"84","author":"Songa","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0805","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1021\/jm201181f","article-title":"Design, synthesis, and qualitative structure-activity evaluations of novel beta-secretase inhibitors as potential Alzheimer's drug leads","volume":"54","author":"Al-Tel","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0810","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/acschemneuro.6b00291","article-title":"Effect of oleracein E, a neuroprotective tetrahydroisoquinoline, on rotenone-induced Parkinson's disease cell and animal models","volume":"8","author":"Sun","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b0815","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmech.2019.02.008","article-title":"Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"167","author":"Fang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0820","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejmech.2016.09.078","article-title":"Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation","volume":"125","author":"Panek","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0825","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/14656566.2013.760543","article-title":"A 10-year perspective on donepezil","volume":"14","author":"Cheewakriengkrai","year":"2013","journal-title":"Exp. Opin. Pharmacother."},{"key":"10.1016\/j.bioorg.2019.103299_b0830","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1529-8817.2008.00596.x","article-title":"Production of natural butylated hydroxytoluene as anantioxidant by freshwater phytoplankton1","volume":"44","author":"Bakthavachalam","year":"2008","journal-title":"J. Phycol."},{"key":"10.1016\/j.bioorg.2019.103299_b0835","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2018.08.005","article-title":"Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties","volume":"157","author":"Cai","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0840","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbi.2016.05.001","article-title":"Coumarins as cholinesterase inhibitors: a review","volume":"254","author":"de Souza","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2019.103299_b0845","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1570180813666160628085515","article-title":"Akbarzadeh, 1,2,3-Triazoleisoxazole based acetylcholinesterase inhibitors: synthesis, biological evaluation and docking study","volume":"14","author":"Najafi","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.bioorg.2019.103299_b0850","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bioorg.2018.10.056","article-title":"Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer\u2032s compounds: in vitro and in vivo biological evaluation and docking study","volume":"83","author":"Najafia","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0855","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1021\/jm0340602","article-title":"3-(4-{[benzyl (methyl) amino] methyl} phenyl)-6, 7-dimethoxy-2h-2-chromenone(ap2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced \u03b2-amyloid aggregation: a dual function lead for Alzheimer\u2019s disease therapy","volume":"46","author":"Piazzi","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0860","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jinorgbio.2017.11.015","article-title":"Santos, Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimer\u2019s disease therapy","volume":"179","author":"Hiremathad","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2019.103299_b0865","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/cbdd.12902","article-title":"Synthesis and anticholinesterase activity of new substituted benzo[d]oxazole-based derivatives","volume":"89","author":"Pouramiri","year":"2017","journal-title":"Chem. Biol. Drug. Des."},{"key":"10.1016\/j.bioorg.2019.103299_b0870","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bioorg.2018.06.006","article-title":"Synthesis and cholinesterase inhibitory activity of new 2-benzofuran carboxamide-benzylpyridinum salts","volume":"80","author":"Abedinifar","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0875","doi-asserted-by":"crossref","first-page":"38","DOI":"10.22159\/ajpcr.2017.v10i7.18461","article-title":"Various biological activities of coumarin and oxadiazole derivatives","volume":"10","author":"Jalhan","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b0880","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bioorg.2016.11.011","article-title":"Synthesis of novel chromenones linked to 1, 2, 3-triazole ring system: investigation of biological activities against Alzheimer\u2019s disease","volume":"70","author":"Saeedi","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0885","first-page":"712","article-title":"Novel indole-isoxazole hybrids: synthesis and in vitro anti-cholinesterase activity","volume":"14","author":"Vafadarnejad","year":"2017","journal-title":"Lett. Drug Des. Dis."},{"key":"10.1016\/j.bioorg.2019.103299_b0890","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bioorg.2018.01.013","article-title":"Design and synthesis of novel coumarin-pyridinium hybrids: in vitro cholinesterase inhibitory activity","volume":"77","author":"Vafadarnejad","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0895","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bmc.2018.12.030","article-title":"Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in alzheimer's disease","volume":"27","author":"Andrade","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0900","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bioorg.2013.06.008","article-title":"Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors","volume":"49","author":"Yoon","year":"2013","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0905","first-page":"36","article-title":"Imidazole and its biological activities: a review","volume":"1","author":"Shalini","year":"2010","journal-title":"Der. Chem. Sin."},{"key":"10.1016\/j.bioorg.2019.103299_b0910","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bioorg.2015.08.002","article-title":"Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease","volume":"62","author":"Rahim","year":"2015","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0915","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bmc.2018.01.029","article-title":"In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer\u2019s disease","volume":"26","author":"Gurjar","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0920","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.bmc.2013.06.003","article-title":"Synthesis, evaluation and molecular dynamics study of some new 4-aminopyridine semicarbazones as an antiamnesic and cognition enhancing agents","volume":"21","author":"Sinha","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0925","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.bmcl.2013.03.026","article-title":"Design, synthesis and evaluation of some new 4-aminopyridine derivatives in learning and memory","volume":"23","author":"Sinha","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b0930","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0960-894X(03)00198-7","article-title":"Synthesis, anticholinesterase activity and structure\u2013activity relationships of m-Aminobenzoic acid derivatives","volume":"13","author":"Trujillo-Ferrara","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b0935","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ejmech.2005.03.011","article-title":"p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors","volume":"40","author":"Correa-Basurto","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0940","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bioorg.2018.10.009","article-title":"Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease","volume":"82","author":"Shrivastava","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0945","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1515\/znc-2016-0087","article-title":"Biological evaluation and docking studies of some benzoxazole derivatives as inhibitors of acetylcholinesterase and butyrylcholinesterase","author":"Temiz-Arpaci","year":"2016","journal-title":"Zeitschrift fur Naturforschung C"},{"key":"10.1016\/j.bioorg.2019.103299_b0950","first-page":"631","article-title":"Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study","volume":"20","author":"Hirbod","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.bioorg.2019.103299_b0955","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2174\/1570159X15666171016163510","article-title":"Computer aided drug design and its application to the development of potential drugs for neurodegenerative disorders","volume":"16","author":"Baig","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2019.103299_b0960","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmech.2018.11.049","article-title":"Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory","volume":"163","author":"Srivastava","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0965","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bioorg.2015.02.002","article-title":"Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives","volume":"59","author":"Kurt","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0970","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.bmc.2016.02.033","article-title":"Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3- alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors","volume":"24","author":"Pejchal","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0975","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bioorg.2018.02.024","article-title":"Synthesis, molecular modelling and biological evaluation of tetrasubstituted thiazoles towards cholinesterase enzymes and cytotoxicity studies","volume":"78","author":"Mumtaz","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0980","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.ejmech.2011.02.071","article-title":"Quinolizidinyl derivatives of bi-and tricyclic systems as potent inhibitors of acetyl-and butyrylcholinesterase with potential in Alzheimer\u2019s disease","volume":"46","author":"Tasso","year":"2011","journal-title":"Eur. J. Med. Chem"},{"key":"10.1016\/j.bioorg.2019.103299_b0985","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1039\/C5MD00274E","article-title":"Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease","volume":"6","author":"Tin","year":"2015","journal-title":"Med. Chem. Commun"},{"key":"10.1016\/j.bioorg.2019.103299_b0990","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bioorg.2018.10.035","article-title":"Design, synthesis and bioevaluation of tricyclic fused ring system as dual binding site acetylcholinesterase inhibitors","volume":"83","author":"Tahir Tanoli","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b0995","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bioorg.2019.02.045","article-title":"Synthesis of 5-methyl-2,4-dihydro-3H-1,2,4-triazole-3-one\u2019s aryl Schiff base derivatives and investigation of carbonic anhydrase and cholinesterase (AChE, BuChE) inhibitory properties","volume":"86","author":"Ozil","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1000","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/14756366.2018.1543288","article-title":"Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies","volume":"34","author":"Cavdar","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14756366.2019.1615484","article-title":"Synthesis and biological evaluation of 3\u2013(4-aminophenyl)-coumarin derivatives as potential anti-Alzheimer\u2019s disease agents","volume":"34","author":"Hu","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1010","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00044-014-1315-3","article-title":"Anticonvulsant activity of 1, 2, 4-triazine derivatives with pyridyl sidevchain: synthesis, biological, and computational study","volume":"24","author":"Irannejad","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b1015","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s11426-010-4094-9","article-title":"Synthesis and biological activity of 3, 6-diaryl-7H-thiazolo [3, 2-b][1, 2, 4] triazin-7-one derivatives as novel acetylcholinesterase inhibitors","volume":"53","author":"Jin","year":"2010","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12035-014-8899-y","article-title":"Neuroprotective role of novel triazine derivatives by activating Wnt\/\u03b2 catenin signaling pathway in rodent models of Alzheimer\u2032s disease","volume":"52","author":"Sinha","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2019.103299_b1025","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1016\/j.bmc.2010.04.097","article-title":"Synthesis and in vitro evaluation of novel 1, 2, 4-triazine derivatives as neuroprotective agents","volume":"18","author":"Irannejad","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1030","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/acschemneuro.8b00024","article-title":"Novel multitarget-directed ligands aiming at symptoms and causes of alzheimer\u2019s disease","volume":"9","author":"Wieckowska","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b1035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bioorg.2018.12.017","article-title":"Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory","volume":"85","author":"Tripathia","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bmcl.2014.11.068","volume":"25","author":"Jiang","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b1045","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/j.bmcl.2016.07.017","volume":"26","author":"Li","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b1050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bioorg.2018.10.057","article-title":"Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE\/BChE inhibitors","volume":"83","author":"Cheng","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1055","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejmech.2014.10.008","article-title":"In search of uracil derivatives as bioactive agents. Uracils and fused uracils: synthesis, biological activity and applications","volume":"97","author":"Palasz","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1060","first-page":"106","article-title":"Design of novel uracil derivatives as inhibitors of carbonic anhydrase I & II, acetylcholinesterase, butyrylcholinesterase, and glutathione reductase using in silico, synthesis and in vitro studies","volume":"283","author":"Durdagi","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2019.103299_b1065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/14756366.2018.1543288","article-title":"Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies","volume":"34","author":"Cavdar","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00018-012-1065-7","volume":"70","author":"Wang","year":"2013","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2019.103299_b1075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","volume":"626","author":"Caraci","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103299_b1080","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.bmc.2013.02.017","volume":"21","author":"Patil","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1085","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3892\/mmr.2014.2040","volume":"9","author":"Cai","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2019.103299_b1090","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1021\/acs.jmedchem.7b00918","article-title":"Coumarin versus chromone monoamine oxidase B inhibitors: quo vadis?","volume":"60","author":"Fonseca","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1095","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/jm2004267","article-title":"Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors","volume":"54","author":"Gaspar","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1100","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.bmcl.2009.03.030","article-title":"Inhibition of monoamine oxidase by (E)-styrylisatin analogues","volume":"19","author":"Van der Walt","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b1105","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1016\/j.bmc.2006.01.011","article-title":"Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC)","volume":"14","author":"Vlok","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.bioorg.2018.01.036","article-title":"3-(E)-Styryl-2H-chromene derivatives as potent and selective monoamine oxidase B inhibitors","volume":"77","author":"Takao","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1115","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2337\/db12-1788","article-title":"Exploring the promise of resveratrol: where do we go from here","volume":"62","author":"Crandall","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bioorg.2019.103299_b1120","first-page":"1114","article-title":"The molecular targets of resveratrol","volume":"2015","author":"Kulkarni","year":"1852","journal-title":"Biochim. Et Biophys. Acta"},{"key":"10.1016\/j.bioorg.2019.103299_b1125","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.3390\/molecules170910052","article-title":"Formononetin attenuates IL-1b-induced apoptosis and NF-kB activation in INS-1 cells","volume":"17","author":"Wang","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103299_b1130","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1021\/jf5050266","article-title":"Enhanced production of resveratrol, piceatannol, arachidin-1 and arachidin-3 in hairy root cultures of peanut co-treated with methyl jasmonate and cyclodextrin","volume":"63","author":"Yang","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tet.2003.10.117","article-title":"Biotransformation of resveratrol: synthesis of trans-dehydrodimers catalyzed by laccases from Myceliophtora thermophyla and from Trametes pubescens","volume":"60","author":"Nicotra","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2019.103299_b1140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejmech.2018.11.040","article-title":"Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease","volume":"163","author":"Tang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1145","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1021\/jm070725e","article-title":"Solid-phase synthesis and insights into structure activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase","volume":"50","author":"Francesco","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1150","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R (+)-Amin-oindan], a selective and potent inhibitor of mitochondrial monoamine oxidase","volume":"132","author":"Moussa","year":"2001","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103299_b1155","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1016\/j.bmc.2018.08.024","article-title":"Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase","volume":"26","author":"Zhoua","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1160","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ardp.19833161112","article-title":"Syntheses and biological activities of some new 4(3H)-quinazolinones","volume":"316","author":"Bahadur","year":"1983","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2019.103299_b1165","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bmc.2008.11.068","article-title":"New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity","volume":"17","author":"Gokhan-Kelekci","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1170","first-page":"514","article-title":"Substituted quinazolones as potent anticonvulsants and enzyme inhibitors","volume":"41","author":"Shrimali","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bioorg.2019.103299_b1175","first-page":"24","article-title":"Monoamine oxidase inhibitory and CNS activities of some quinazolinones","volume":"32","author":"Lata","year":"1982","journal-title":"Arzneimittelforschung"},{"issue":"5","key":"10.1016\/j.bioorg.2019.103299_b1180","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0031-6989(77)80029-5","article-title":"Styrlquinazolones as monoamine oxidase inhibitors","volume":"9","author":"Misra","year":"1977","journal-title":"Pharmacol. Res. Commun."},{"key":"10.1016\/j.bioorg.2019.103299_b1185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/prac.19723140124","article-title":"Synthesis of substituted 2-methyl-3 (4\u2032-hydrazinocarbonyl-methylene-oxy-phenyl)-4-quinazolones as monoamine oxidase inhibitors","volume":"314","author":"Rastogi","year":"1972","journal-title":"J. Prakt. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1190","first-page":"14","article-title":"Design, synthesis and characterization of novel 6, 7-dimethoxy-N 2-(substituted benzyl)-N 2-propylquinazoline-2, 4-diamine derivatives as anxiolytic and antidepressant agents","volume":"3","author":"Srivastav","year":"2013","journal-title":"Am. J. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bioorg.2018.12.030","article-title":"The monoamine oxidase inhibition properties of C6-mono- and N3\/C6-disubstituted derivatives of 4(3H)-quinazolinone","volume":"85","author":"Qhobosheane","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmech.2016.02.038","article-title":"Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors","volume":"114","author":"Hammuda","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1205","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/14756366.2019.1593158","article-title":"SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs","volume":"34","author":"Shalaby","year":"2019","journal-title":"J Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejmech.2012.10.032","volume":"58","author":"Secci","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360109162369","volume":"16","author":"Gritsch","year":"2001","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.bioorg.2019.103299_b1220","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.bmc.2014.03.042","volume":"22","author":"D'Ascenzio","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1225","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3109\/14756366.2014.987138","volume":"30","author":"D'Ascenzio","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1230","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1021\/jm100120s","volume":"53","author":"Chimenti","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1235","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejmech.2017.12.013","volume":"144","author":"Can","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bioorg.2018.12.019","article-title":"In vitro and in silico evaluation of new thiazole compounds as monoamine oxidase inhibitors","volume":"85","author":"Saglik","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1245","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bioorg.2019.103299_b1250","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science (Washington, DC, U. S.)"},{"key":"10.1016\/j.bioorg.2019.103299_b1255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer\u2019s disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bioorg.2019.103299_b1260","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejmech.2016.02.049","article-title":"Amyloid cascade in Alzheimer\u2019s disease: recent advances in medicinal chemistry","volume":"113","author":"Mohamed","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/jm049156q","volume":"48","author":"Bolognesi","year":"2005","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2015.10.018","article-title":"Pivotal role of glycogen synthase kinase-3: a therapeutic target for Alzheimer's disease","volume":"107","author":"Maqbool","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-014-0213-z","article-title":"Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders","volume":"29","author":"Leary","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bioorg.2019.103299_b1280","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jalz.2016.03.018","article-title":"Tau: from research to clinical development","volume":"12","author":"Holtzman","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bioorg.2019.103299_b1285","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2174\/156720512802455386","article-title":"Roles of glycogen synthase kinase 3 in Alzheimer\u2019s disease","volume":"9","author":"Cai","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bioorg.2019.103299_b1290","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b1295","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bmcl.2015.03.046","article-title":"Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core","volume":"25","author":"Sivaprakasam","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b1300","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejmech.2019.02.001","article-title":"Synthesis and evaluation of novel GSK-3\u03b2 inhibitors as multifunctional agents against Alzheimer's disease","volume":"167","author":"Shi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1305","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1039\/C4CS00138A","volume":"43","author":"Barnham","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2019.103299_b1310","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acs.accounts.5b00119","volume":"48","author":"Robert","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b1315","doi-asserted-by":"crossref","first-page":"17085","DOI":"10.1002\/chem.201502824","volume":"21","author":"Nguyen","year":"2015","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2019.103299_b1320","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ejic.201601120","volume":"3","author":"Nguyen","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1325","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/cmdc.201700734","article-title":"Preparation of new tetradentate copper chelators as potential anti-Alzheimer agents","volume":"13","author":"Robert","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2019.103299_b1330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1745-7254.2006.00255.x","article-title":"Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2019.103299_b1335","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1340","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.neuro.2009.08.013","article-title":"Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation","volume":"30","author":"Feng","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bioorg.2019.103299_b1345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1878-5085-4-5","article-title":"Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?","volume":"4","author":"Mahler","year":"2013","journal-title":"EPMA J."},{"key":"10.1016\/j.bioorg.2019.103299_b1350","first-page":"390","article-title":"Effects of sarsasapogenin on deposition of \u03b2-amyloid peptide and cholinergic function in rats with \u03b2-amyloid injection into right nucleus basalis magnocellularis","volume":"1","author":"Chen","year":"2002","journal-title":"Zhong Guo Yao Li Xue Tong Bao"},{"key":"10.1016\/j.bioorg.2019.103299_b1355","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bmcl.2016.11.070","article-title":"Synthesis and SAR study of novel sarsasapogenin derivatives as potent neuroprotective agents and NO production inhibitors","volume":"27","author":"Pan","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103299_b1360","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.steroids.2017.06.013","article-title":"Synthesis and evaluation of -amino acid methyl ester substituted sarsasapogenin derivatives as neuroprotective agents for Alzheimer\u2019s disease","volume":"125","author":"Wang","year":"2017","journal-title":"Steroids"},{"key":"10.1016\/j.bioorg.2019.103299_b1365","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinorgbio.2016.04.022","article-title":"Multifunctional quinoline-triazole derivatives as potential modulators of amyloid-beta peptide aggregation","volume":"158","author":"Jones","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2019.103299_b1370","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejmech.2018.03.082","article-title":"Novel sarsasapogenin-triazolyl hybrids as potential anti-Alzheimer's agents: design, synthesis and biological evaluation","volume":"151","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1375","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fchem.2018.00178","article-title":"Highlights in BACE1 inhibitors for Alzheimer's disease treatment","volume":"6","author":"Coimbra","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1380","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","article-title":"The secretases: enzymes with therapeutic potential in Alzheimer disease","volume":"6","author":"De Strooper","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bioorg.2019.103299_b1385","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bioorg.2018.01.017","article-title":"Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer\u2019s disease","volume":"77","author":"Iraji","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1390","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/C3CS60460H","article-title":"BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer\u2019s disease","volume":"43","author":"Ghosh","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2019.103299_b1395","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bioorg.2017.07.014","article-title":"Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer\u2019s disease","volume":"74","author":"Haghighijoo","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1400","doi-asserted-by":"crossref","first-page":"102936","DOI":"10.1016\/j.bioorg.2019.102936","article-title":"Fluoro-benzimidazole derivatives to cure Alzheimer\u2032s disease: in-silico studies, synthesis, structure-activity relationship and in vivo evaluation for \u03b2-secretase enzyme inhibition","volume":"88","author":"Ali","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1405","doi-asserted-by":"crossref","first-page":"37820","DOI":"10.1074\/jbc.M605336200","article-title":"Side chain-dependent stacking modulates tau filament structure","volume":"281","author":"Margittai","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1410","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","article-title":"Assembly of \u03c4 protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming \u03b2 structure","volume":"97","author":"Bergen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2019.103299_b1415","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","article-title":"Propagation of tau aggregates and neurodegeneration","volume":"40","author":"Goedert","year":"2017","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b1420","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/med.21518","article-title":"Death-associated protein kinase (DAPK) family modulators: current and future therapeutic outcomes","volume":"39","author":"Farag","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2019.103299_b1425","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nrd2999","article-title":"Targeting protein kinases in central nervous system disorders","volume":"8","author":"Chico","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103299_b1430","series-title":"Comprehensive Medicinal Chemistry III","first-page":"408","article-title":"Inhibiting kinases in the CNS","author":"Tsui","year":"2017"},{"key":"10.1016\/j.bioorg.2019.103299_b1435","doi-asserted-by":"crossref","first-page":"25663","DOI":"10.1038\/srep25663","article-title":"CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves","volume":"6","author":"Martinez-Muriana","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2019.103299_b1440","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awv379","article-title":"Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology","volume":"139","author":"Olmos-Alonso","year":"2016","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bioorg.2019.103299_b1445","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b1450","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2018.10.057","article-title":"First-in-class DAPK1\/CSF1R dual inhibitors: discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potentialanti-tauopathies agent","volume":"169","author":"Farag","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1455","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1021\/acs.biochem.7b00137","article-title":"Exploring the influence of domain architecture on the catalytic function of diterpene synthases","volume":"56","author":"Pemberton","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2019.103299_b1460","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/14756366.2014.930453","article-title":"Antibacterial antioxidant and hypoglycaemic effects of Thymus capitatus (L.) Hoffmanns. et Link leaves\u2019 fractions","volume":"30","author":"Iauk","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1465","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tplants.2008.09.005","article-title":"Facchini Got milk? The secret life of laticifers","volume":"13","author":"Hagel","year":"2008","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.bioorg.2019.103299_b1470","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/cr078350s","article-title":"Chemical and pharmacological research of the plants in genus Euphorbia","volume":"108","author":"Shi","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2019.103299_b1475","first-page":"498","article-title":"Phytochemical analysis and evaluation of antioxidant and anti-acetylcholinesterase activities of Euphorbia dendroides L. (Euphorbiaceae) latex","volume":"153","author":"Smeriglio","year":"2019","journal-title":"Plant Biosyst. Int. J. Deal. Asp. Plant Biol."},{"key":"10.1016\/j.bioorg.2019.103299_b1480","first-page":"88","article-title":"Endophytes from marine macroalgae: promising sources of novel natural products","volume":"109","author":"Flewelling","year":"2015","journal-title":"Curr. Sci."},{"key":"10.1016\/j.bioorg.2019.103299_b1485","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/14786419.2018.1455037","article-title":"Aromatic compounds produced by endophytic fungi isolated from red alga Asparagopsis taxiformis - Falkenbergia stage","volume":"33","author":"Medina","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2019.103299_b1490","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/md6040578","article-title":"Acetylcholinesterase-inhibiting activity of pyrrole derivatives from a novel marine gliding bacterium, Rapidithrix thailandica","volume":"6","author":"Sangnoi","year":"2008","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioorg.2019.103299_b1495","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1570159X11311040004","article-title":"Natural AChE inhibitors from plants and their contribution to Alzheimer\u2019s disease therapy","volume":"11","author":"Murray","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2019.103299_b1500","doi-asserted-by":"crossref","first-page":"12318","DOI":"10.1038\/s41598-019-48655-7","article-title":"Botryane terpenoids produced by Nemania bipapillata, an endophytic fungus isolated from red alga Asparagopsis taxiformis -Falkenbergia stage","volume":"9","author":"Medina","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2019.103299_b1505","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1590\/S0100-40422013000600006","volume":"36","author":"Uchoa","year":"2013","journal-title":"Quim. Nova"},{"key":"10.1016\/j.bioorg.2019.103299_b1510","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1021\/np050503o","volume":"69","author":"Tavares","year":"2006","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2019.103299_b1515","first-page":"94","volume":"85","author":"Olivier","year":"2013","journal-title":"J. Bot."},{"key":"10.1016\/j.bioorg.2019.103299_b1520","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.fitote.2011.12.022","volume":"83","author":"Hernandez","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2019.103299_b1525","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bioorg.2018.04.011","article-title":"New AChE inhibitors from microbial transformation of trachyloban-19-oic acid by Syncephalastrum racemosum","volume":"79","author":"Dos Santos","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1530","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fnagi.2017.00168","article-title":"Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants","volume":"9","author":"Ayaz","year":"2017","journal-title":"Front. Ag. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103299_b1535","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ffj.2045","article-title":"Actions of essential oils on the central nervous system: an updated review","volume":"26","author":"Dobetsberger","year":"2011","journal-title":"Flavour Fragr. J."},{"key":"10.1016\/j.bioorg.2019.103299_b1540","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.fct.2013.06.040","article-title":"Chemistry and functional properties in prevention of neurodegenerative disorders of five Cistus species essential oils","volume":"59","author":"Loizzo","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2019.103299_b1545","first-page":"H40","article-title":"Comparative study on the antioxidant capacity and cholinesterase inhibitory activity of Citrus aurantifolia Swingle, C. aurantium L. and C. bergamia Risso & Poit peel essential oils","volume":"71","author":"Tundis","year":"2012","journal-title":"J. Food Sci."},{"key":"10.1016\/j.bioorg.2019.103299_b1550","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/antiox8010002","article-title":"Potential Application of Prunus armeniaca L. and P. domestica L. leaf essential oils as antioxidant and of cholinesterases inhibitors","volume":"8","author":"Bonesi","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioorg.2019.103299_b1555","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejmech.2014.01.020","volume":"75","author":"Thiratmatrakul","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1560","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/anie.201104150","volume":"51","author":"Yang","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2019.103299_b1565","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1042\/bj3430419","volume":"343","author":"Howlett","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2019.103299_b1570","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2014.02.035","volume":"76","author":"Fang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1575","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ardp.201400365","article-title":"9H-carbazole derivatives containing the N-Benzyl-1,2,3-triazole moiety as new acetylcholinesterase inhibitors","volume":"348","author":"Akrami","year":"2015","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.bioorg.2019.103299_b1580","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejmech.2016.09.037","article-title":"New azepino [4, 3-b] indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity","volume":"125","author":"de Candia","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1585","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2018.05.031","article-title":"Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and \u03b2-secretase inhibition activities","volume":"15","author":"Ghobadian","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1590","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejmech.2014.01.020","article-title":"Synthesis, biological evaluation and molecular modeling study of novel for the treatment of Alzheimer's disease","volume":"75","author":"Thiratmatrakul","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1595","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/anie.201104150","article-title":"Inhibition of betaamyloid peptide aggregation by multifunctional carbazole based fluorophores","volume":"51","author":"Yang","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2019.103299_b1600","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1021\/jm1000024","article-title":"Bivalent \u03b2-carbolines as potential multitarget anti-alzheimer agents","volume":"53","author":"Rook","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103299_b1605","first-page":"29","article-title":"New classes of carbazoles as potential multi-functional anti-Alzheimer\u2019s agents","volume":"29","author":"Choubdar","year":"2019","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681931154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681931154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:55:27Z","timestamp":1758614127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520681931154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":321,"alternative-id":["S004520681931154X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103299","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical evaluation of current Alzheimer\u2019s drug discovery (2018\u201319) & futuristic Alzheimer drug model approach","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103299"}}